Clinical Trials Browser

Has results × Gliosarcoma × sargramostim × Clear all

NCT02455557 2026-03-30

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 2 Active not recruiting

66 enrolled 11 charts

Glioblastoma, Gliosarcoma

NCT00643097 2017-02-01

ACTIVATe

Phase 2 Completed

40 enrolled 9 charts

Glioblastoma, Gliosarcoma